Keyword: Hospira

Pfizer is offering some 1,700 door-heading employees "an attractive financial scheme that is significantly higher than the legal requirements."

Pfizer's plan to close two legacy Hospira plants in India puts 1,700 jobs stationed there at risk.

The FDA’s Center for Veterinary Medicine has reached an agreement for Pfizer to divert part of a new source of injected pain drugs to veterinarians.

The most recent inspection of Pfizer's troubled injectables plant in McPherson, Kansas, found eight observations, seven of them repeats.

A hospital-backed group, Civica Rx intends to manufacture or contract the production of 14 drugs that are in chronic supply.

Pfizer says that its former Hospira plants that produces injected opioids for use in hospitals was reinspected this month by the FDA.

Pfizer has again suspended production at a long-troubled sterile injectables plant in India that the FDA has twice before cited.

Pfizer’s latest overhaul sets biosimilars and hospital drugs alongside innovative products, where they can get brand-level attention.

After a couple of misfires, Pfizer has finally won FDA approval for its biosimilar of $1.8 billion anemia drug Epogen,

Pfizer’s Hospira has issued a voluntary recall of three lots of the painkiller hydromorphone, an injectable, due to an apparent manufacturing issue that could lead to the glass vials being either empty or cracked.